Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report | Zendy

Uğur Önal | Zendy; Meltem Taşbakan | Zendy; Tansu Yamazhan | Zendy; Bilgin Arda | Zendy; Hüsnü Pullukçu | Zendy; Sercan Ulusoy | Zendy; Oğuz Reşat Sıpahı | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report

Author(s) -

Uğur Önal,

Meltem Taşbakan,

Tansu Yamazhan,

Bilgin Arda,

Hüsnü Pullukçu,

Sercan Ulusoy,

Oğuz Reşat Sıpahı

Publication year - 2016

Publication title -

journal of microbiology and infectious diseases

Language(s) - English

Resource type - Journals

eISSN - 2146-9369

pISSN - 2146-3158

DOI - 10.5799/ahinjs.02.2016.01.0211

Subject(s) - posaconazole , deferasirox , mucormycosis , medicine , amphotericin b , antifungal , intensive care medicine , pharmacology , dermatology , surgery , thalassemia

In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal\udamphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery. There was no relapse on\ud6 month post-treatment follow-up. We conclude that combination of antifungal antibiotics with deferasirox may be\udsuccessful in the salvage therapy of mucormycosis especially in diabetic patients. J Microbiol Infect Dis 2016;6(1): 32-3

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research